Clinical trials
Phase 3 Hypertension trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 6 |
| 2008 | 1 |
| 2018 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Novartis | 4 |
| Novartis Pharmaceuticals | 4 |
| Eli Lilly and Company | 3 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 3 |
| Alnylam Pharmaceuticals | 1 |
| Boehringer Ingelheim | 1 |
| Pfizer | 1 |
| Population Health Research Institute | 1 |
| Solvay Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 24 |
| Cardiovascular Diseases | 2 |
| Renal Insufficiency, Chronic | 2 |
| Diabetes Mellitus | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
| Hyperlipidemias | 1 |
| Hypotension | 1 |
| Obesity | 1 |
| Overweight | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.